{"id":2569,"company":{"country":"GB","currency":"GBP","exchange":"LONDON STOCK EXCHANGE","ipo":"1972-05-22","marketCap":59331.23828125,"name":"GSK plc","phone":"442080475000","outstanding":4076.14990234375,"symbol":"GSK","website":"https://www.gsk.com/","industry":"Pharmaceuticals"},"price":37.20125,"year":2024,"month":1,"day":3,"weekday":"Wednesday","title":"Historical Volatility of GSK plc Stock and Its Impact on Investor Behavior","date":"2024-01-03","url":"/posts/2024/01/03/GSK","content":[{"section":"Historical Volatility of GSK plc Stock","text":"GSK plc is a global pharmaceutical company listed on the London Stock Exchange. To analyze its historical volatility, we can examine the price movements of GSK plc stock over a specific time period, such as the past year or five years. Volatility refers to the degree of variation in stock prices over time."},{"section":"Impact on Investor Behavior","text":"High historical volatility in GSK plc stock can impact investor behavior in several ways. Firstly, it may attract traders who seek short-term gains through active buying and selling based on price fluctuations. These traders aim to capitalize on short-term volatility to generate profits."},{"section":"","text":"Secondly, high volatility can deter conservative, long-term investors who prioritize stability and predictability. They may perceive high volatility as increased risk and opt for less volatile investment options. This can result in decreased demand for GSK plc stock from long-term investors."},{"section":"Risk Management","text":"Managing the risk associated with the historical volatility of GSK plc stock is crucial for investors. Risk management strategies include diversification, where investors allocate their portfolio across different asset classes to reduce exposure to a single stock's volatility. Additionally, investors can also consider using stop-loss orders or options contracts to protect against large losses in case of sudden price declines."},{"section":"","text":"Furthermore, some investors may monitor historical volatility trends to identify periods of heightened risk and adjust their investment strategies accordingly. They may choose to reduce their exposure to GSK plc stock during periods of high volatility or increase it during relative stability, depending on their risk tolerance and investment goals."},{"section":"","text":"In summary, the historical volatility of GSK plc stock can significantly impact investor behavior. High volatility may attract short-term traders while deterring conservative, long-term investors. Risk management strategies such as diversification and monitoring historical volatility help investors mitigate the risks associated with GSK plc stock's volatility."}],"tags":["LongSignals","Long","Pharmaceuticals"],"news":[{"category":"company","date":1704179760,"headline":"Spero announces first patient, first visit for Phase 3 PIVOT-PO trial","id":124805536,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3281085033"},{"category":"company","date":1703995020,"headline":"Warning: GSK is at high risk of cutting its dividend","id":124789672,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3279124373"},{"category":"company","date":1703865240,"headline":"How Lowering The Price of a Common Asthma Drug Made It Harder to Get","id":124764967,"image":"","symbol":"GSK","publisher":"Yahoo","summary":"To avoid Medicaid penalties, Glaxo and other drugmakers lowered prices. For popular asthma drug Flovent HFA, the tactic to replace it with a generic backfired.","url":"https://finance.yahoo.com/m/0f9ead80-450f-3e51-ae4e-1fa8520d13f0/how-lowering-the-price-of-a.html"},{"category":"company","date":1703852820,"headline":"Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves","id":124767720,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277269672"},{"category":"company","date":1703851380,"headline":"GSK falls Friday, underperforms market","id":124785792,"image":"https://images.mktw.net/im-220105/social","symbol":"GSK","publisher":"MarketWatch","summary":"Shares of GSK PLC inched down 0.75% to £14.50 Friday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index...","url":"https://www.marketwatch.com/data-news/gsk-falls-friday-underperforms-market-4a17a73a-5f61421a5825"},{"category":"company","date":1703849040,"headline":"Drugmakers reportedly planning to raise prices on 500+ drugs in January (update)","id":124767182,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277210003"},{"category":"company","date":1703848020,"headline":"Drugmakers reportedly planning to raise prices on 500+ drugs in January","id":124767183,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277194255"},{"category":"company","date":1703847480,"headline":"What You Missed On Wall Street This Morning","id":124766197,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277185484"},{"category":"company","date":1703842440,"headline":"Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January","id":124767185,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277109111"},{"category":"company","date":1703839260,"headline":"Uber and Lyft downgraded: Wall Street's top analyst calls","id":124767725,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277060611"},{"category":"company","date":1703836860,"headline":"LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023","id":124764507,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=pnfpxgmc94"},{"category":"company","date":1703836621,"headline":"Investing in GSK (LON:GSK) five years ago would have delivered you a 22% gain","id":124764968,"image":"https://media.zenfs.com/en/simply_wall_st__316/a99782b24065c2e10ff5cc21f6727f48","symbol":"GSK","publisher":"Yahoo","summary":"In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...","url":"https://finance.yahoo.com/news/investing-gsk-lon-gsk-five-075701723.html"},{"category":"company","date":1703834880,"headline":"GSK comments underscore Verona as potential target, says H.C. Wainwright","id":124767727,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3276998428"},{"category":"company","date":1703820420,"headline":"What You Missed On Wall Street On Friday","id":124771214,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277443024"},{"category":"company","date":1703811900,"headline":"Drugmakers Set to Hike Prices on Over 500 Medications","id":124768335,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3277306431"},{"category":"company","date":1703765040,"headline":"GSK rises Thursday, outperforms market","id":124785793,"image":"https://images.mktw.net/im-220105/social","symbol":"GSK","publisher":"MarketWatch","summary":"GSK PLC shares inched up 0.80% to £14.61 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index...","url":"https://www.marketwatch.com/data-news/gsk-rises-thursday-outperforms-market-3d1097ac-365d96cd5f71"},{"category":"company","date":1703757540,"headline":"February 2024 Options Now Available For GSK","id":124756564,"image":"","symbol":"GSK","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3275830227"},{"category":"company","date":1703751960,"headline":"Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024","id":124745257,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3275747765"},{"category":"company","date":1703678580,"headline":"GSK remains steady Wednesday, underperforms market","id":124785794,"image":"https://images.mktw.net/im-220105/social","symbol":"GSK","publisher":"MarketWatch","summary":"Shares of GSK PLC were unchanged Wednesday at £14.50, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100...","url":"https://www.marketwatch.com/data-news/gsk-remains-steady-wednesday-underperforms-market-adaf8a3d-9263a6bf3ba1"},{"category":"company","date":1703676840,"headline":"FDA’s new drug approvals for 2023 rise 51% from last year","id":124725699,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3274632530"},{"category":"company","date":1703586720,"headline":"GSK looking to boost pipeline with respiratory, auto-immune deals - report","id":124711603,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3273401173"},{"category":"company","date":1703496000,"headline":"Merck: Smart Value For Potentially Strong Total Returns","id":124702611,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1248262649/image_1248262649.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"Merck remains undervalued with a strong set of growing drugs and new indications in its pipeline. Read more about MRK stock here.","url":"https://seekingalpha.com/article/4659535-merck-smart-value-for-potentially-strong-total-returns"},{"category":"company","date":1703457282,"headline":"15 Undervalued Defensive Stocks For 2024","id":124699256,"image":"https://media.zenfs.com/en/insidermonkey.com/9310cc71c6b9d6df7dbb9a058d0c1c4a","symbol":"GSK","publisher":"Yahoo","summary":"In this article, we discuss the 15 undervalued defensive stocks for 2024. To skip the detailed overview of the market and defensive stocks, go directly to the 5 Undervalued Defensive Stocks For 2024. Defensive stocks are shares of companies that remain relatively stable during economic downturns as opposed to cyclical stocks. Defensive stocks usually outperform […]","url":"https://finance.yahoo.com/news/15-undervalued-defensive-stocks-2024-223442627.html"},{"category":"company","date":1703424600,"headline":"Week In Review: Two Billion-Dollar Deals As 2023 Nears End - Hansoh-GSK; Nona-Pfizer","id":124696798,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/991799206/image_991799206.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"GSK acquired ex-Greater China rights to a second ADC from Hansoh Pharma in a $1.7 billion agreement. Boston's Nona Biosciences out-licensed global rights for its MSLN-targeted ADC to Pfizer.","url":"https://seekingalpha.com/article/4659466-week-in-review-two-billion-dollar-deals-2023-nears-end-hansoh-gsk-nona-pfizer"},{"category":"company","date":1703305133,"headline":"AbbVie Vs. GSK: Dual Dominance In Pharma","id":124688080,"image":"https://media.gettyimages.com/id/1432338461/photo/medicine-healthcare-and-pills-in-the-hands-of-a-senior-man-sitting-on-a-sofa-in-the.jpg?b=1\u0026s=170667a\u0026w=0\u0026k=20\u0026c=jmQxvdCAhNO-twNnhV9TbonmMk4vzdnuK0d7odxG4d8=","symbol":"GSK","publisher":"SeekingAlpha","summary":"AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. Explore more details here.","url":"https://seekingalpha.com/article/4659359-abbvie-vs-gsk-dual-dominance-in-pharma"},{"category":"company","date":1703281907,"headline":"GSK to cut US prices for Advair, Valtrex and Lamictal","id":124678046,"image":"https://media.zenfs.com/en/reuters-finance.com/961f4d3e77a807cf6dc1ea9a8b6c2c3a","symbol":"GSK","publisher":"Yahoo","summary":"The price cuts come after several companies have already announced price decreases for insulins earlier this year as they worked to avoid potential penalties under 2021's American Rescue Plan Act if they had kept prices high.  Under the law, drug companies are required to rebate the Medicaid program if price increases on medicines outpace inflation - and beginning in January 2024 those rebates could even be larger than the actual net cost of the drug.  According to a GSK spokesman, the company plans to cut list prices by up to 70% on Advair, up to 48% on Lamictal and 10% for Valtrex.","url":"https://finance.yahoo.com/news/gsk-cut-us-prices-advair-215147879.html"},{"category":"company","date":1703263019,"headline":"3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth","id":124747564,"image":"https://media.zenfs.com/en/investorplace_417/441c089d5147eb505836fae2173dd97c","symbol":"GSK","publisher":"Yahoo","summary":"Growth at a reasonable price (GARP) stocks represent a middle ground between growth stocks with high valuations and very conservative value stocks. While growth stocks with high valuations could easily plunge or even go to $0 due to bankruptcy, GARP stocks are unlikely to do either. That’s because their low valuations and generally strong balance sheets make these scenarios very improbable. However, because the companies issuing GARP stocks can grow very rapidly, their shares can climb tremendou","url":"https://finance.yahoo.com/news/3-growth-reasonable-price-garp-163659350.html"},{"category":"company","date":1703171129,"headline":"Sunak hosts bosses for Business Council gathering","id":124653711,"image":"https://s.yimg.com/ny/api/res/1.2/B_BRBj..ZJzrLCtSvioHNg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/snappa.ukfinance/8b4eea188f97d06ec50546d35e9569ea","symbol":"GSK","publisher":"Yahoo","summary":"The group agreed there could be more economic growth and dynamism next year, Downing Street said.","url":"https://uk.finance.yahoo.com/news/sunak-hosts-bosses-business-council-173716767.html"},{"category":"company","date":1703145300,"headline":"Merck's Chronic Cough Treatment Candidate Receives Second Time FDA Rejection","id":124651048,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3267302552"},{"category":"company","date":1703142780,"headline":"Vertex announces appointment of three new leaders","id":124643083,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3267257555"},{"category":"company","date":1703073840,"headline":"GSK rises Wednesday, still underperforms market","id":124707269,"image":"https://images.mktw.net/im-220105/social","symbol":"GSK","publisher":"MarketWatch","summary":"GSK PLC shares inched up 0.87% to £14.45 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index...","url":"https://www.marketwatch.com/data-news/gsk-rises-wednesday-still-underperforms-market-33cb1f9e-2eb516fb0dba"},{"category":"company","date":1703066400,"headline":"COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs","id":124634547,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3265769481"},{"category":"company","date":1703059800,"headline":"GSK agrees to pay up to $1.7 billion for antibody-drug conjugate","id":124660819,"image":"https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg","symbol":"GSK","publisher":"MarketWatch","summary":"GSK PLC said Wednesday that it has agreed to pay $185 million up front and up to $1.525 billion in success-based milestone payments to license an...","url":"https://www.marketwatch.com/story/gsk-agrees-to-pay-up-to-1-7-billion-for-antibody-drug-conjugate-cd64ddce"},{"category":"company","date":1703059020,"headline":"GSK Enters Exclusive License Agreement With Hansoh for HS-20093 Cancer Antibody","id":124707271,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"GSK","publisher":"MarketWatch","summary":"By Ian Walker GSK has entered into an exclusive license agreement with Hansoh Pharmaceutical Group for its HS-20093 antibody-drug cancer treatment, with...","url":"https://www.marketwatch.com/story/gsk-enters-exclusive-license-agreement-with-hansoh-for-hs-20093-cancer-antibody-8fb6f0d1"},{"category":"company","date":1703054580,"headline":"GSK enters exclusive license agreement with Hansoh for HS-20093","id":124651052,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3265538382"}]}